首页|诃子水提物对高尿酸肾病大鼠的保护作用及机制研究

诃子水提物对高尿酸肾病大鼠的保护作用及机制研究

扫码查看
目的:探究诃子水提物改善高尿酸肾病大鼠的作用及初步机制。方法:通过中药系统药理学分析平台(TCMSP)获取诃子活性成分及靶点信息,GeneCards数据库收集高尿酸肾病相关靶点。利用STRING数据库进行蛋白互作(PPI)分析;运用Metas-cape平台进行基因本体(GO)和京都基因与基因组百科全书(KEGG)通路富集分析;通过Cytoscape 3。7软件构建"诃子-活性成分-交集靶点-疾病"网络图。利用Autodock vina软件对诃子核心成分与关键靶点进行分子对接,并通过pkCSM数据库预测核心成分的ADMET性与类药性。采用氧嗪酸钾联合10%果糖诱导构建高尿酸肾病大鼠模型,通过对血清及尿液的肾功能指标检测及肾组织HE、PAS和Masson染色,验证诃子水提物的保护作用。采用CCK8、RT-PCR及Western blot等方法验证诃子水提物及其核心成分对尿酸诱导的HK-2肾损伤细胞模型及关键靶点的作用。结果:收集获得7个诃子活性成分,成分靶点70个,高尿酸肾病相关靶点878个,药-病交集靶点22个。GO富集分析表明,诃子主要影响白细胞凋亡、对有机环状化合物的细胞反应、对肿瘤坏死因子的反应等生物过程;发挥与蛋白质特定结构域结合、参与凋亡信号通路的半胱氨酸型内肽酶活性、BH3结构域结合等分子功能;涉及膜微区、转录调节复合物、受体复合物等细胞组分,进而起到治疗高尿酸肾病的作用。KEGG富集分析表明,诃子治疗高尿酸肾病涉及的主要通路为P53信号通路、凋亡信号通路等。TP53、ESR1、CASP8、CASP9和CASP3是诃子治疗高尿酸肾病的关键靶点。分子对接结果显示诃子核心成分与关键靶点具有良好的结合能力,且ADMET性与类药性分析表明核心成分均具有良好的成药性。动物实验表明,诃子水提物显著降低高尿酸肾病大鼠血清尿酸(SUA)、肌酐(Scr)、尿素氮(BUN)和24 h尿蛋白含量(P<0。05或P<0。01),并改善肾组织病理损伤。细胞实验表明,诃子水提物及其核心成分有效提高了尿酸诱导的HK-2细胞活力,改善细胞状态。在分子水平上,诃子水提物显著下调了Casp8和Casp3 mRNA的表达(P<0。01),碎叶紫堇碱显著下调Tp53 mRNA的表达(P<0。01),而硫酸奎尼丁明显下调TP53、ESR1、CASP8、CASP9和CASP3蛋白和mRNA表达(P<0。05或P<0。01)。结论:诃子水提物能够改善高尿酸肾病大鼠的肾损伤,其作用机制可能是基于其核心成分硫酸奎尼丁通过抗凋亡途径实现的。
Protective Effects and Mechanisms of CHEBULAE FRUCTUS Water Extract in Rats with Hyperuricemic Nephropathy
Objective:To investigate the effects and preliminary mechanisms of CHEBULAE FRUCTUS water extract in improving hyperuricemic ne-phropathy in rats.Methods:Active components and target information of CHEBULAE FRUCTUS were obtained through the Traditional Chi-nese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP),and targets related to hyperuricemic nephropathy were col-lected from the GeneCards database.Subsequently,protein-protein interaction (PPI) analysis was performed by using the STRING database.Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed via Metascape platform."CHEBULAE FRUCTUS-active components-intersecting targets-disease" network diagram was constructed by Cytoscape 3.7.1 soft-ware.Autodock Vina software was employed for the molecular docking of core components of CHEBULAE FRUCTUS with key targets,and the ADMET properties and drug-likeness of the core components were predicted by the pkCSM database.A rat model of hyperuricemic nephropa-thy was established by using potassium oxonate combined with 10% fructose,and the protective effect of CHEBULAE FRUCTUS water extract was verified through renal function index tests of serum and urine,as well as HE,PAS,and Masson staining of renal tissue.The effects of CHEBULAE FRUCTUS water extract and its core components on the uric acid-induced HK-2 renal injury cell model and key targets were vali-dated using methods such as CCK8,RT-PCR,and Western blot.Results:Seven active components of CHEBULAE FRUCTUS were identified,with 70 component targets,878 hyperuricemic nephropathy-related targets,and 22 drug-disease intersecting targets.GO enrichment analysis indicated that CHEBULAE FRUCTUS mainly affected biological processes such as leukocyte apoptosis,cellular responses to organic cyclic compounds,and responses to tumor necrosis factors.It exerted molecular functions such as binding to specific protein domains,cysteine-type endopeptidase activity in the apoptotic signaling pathway,and BH3 domain binding,involving cellular components such as membrane mi-crodomains,transcription regulation complexes,and receptor complexes and thereby playing a role in treating hyperuricemic nephropathy.KEGG enrichment analysis revealed that the main pathways involved in the treatment of hyperuricemic nephropathy by CHEBULAE FRUCTUS were the P53 signaling pathway,apoptosis signaling pathway,etc.TP53,ESR1,CASP8,CASP9,and CASP3 were key targets in the treatment of hyperuricemic nephropathy by CHEBULAE FRUCTUS.Additionally,molecular docking results showed that the core components of CHE-BULAE FRUCTUS had good binding ability with key targets,and ADMET properties and drug-likeness analyses indicated that all core compo-nents had good drug properties.Animal experiments indicated that CHEBULAE FRUCTUS water extract significantly reduced the contents of serum uric acid (SUA),serum creatinine (Scr),blood urea nitrogen (BUN),and 24-hour urinary protein levels in rats with hyperuricemic nephropathy (P<0.05 or P<0.01) and improved pathological damage of renal tissue.Cell experiments showed that CHEBULAE FRUCTUS water extract and its core components effectively enhanced the viability of uric acid-induced HK-2 cells and improved cell condition.At the molecular level,CHEBULAE FRUCTUS water extract significantly down-regulated the gene expression of Casp8 and Casp3 (P<0.01),and the cheilanthifoline significantly down-regulated Tp53 gene expression (P<0.01).Quinidine sulfate significantly down-regulated the gene and protein expression of Tp53,Esr1,Casp8,Casp9,and Casp3 (P<0.05 or P<0.01).Conclusion:CHEBULAE FRUCTUS water extract can im-prove renal injury in rats with hyperuricemic nephropathy,and its mechanism of action may be based on its core components Quinidine sulfate acting through the anti-apoptotic pathway.

CHEBULAE FRUCTUS water extractHyperuricemic nephropathyNetwork pharmacologyMolecular dockingApoptosisQuinidine sulfate

刘豪、沈娟、刘文彬、金小宝

展开 >

广东药科大学基础医学院,广东省生物活性药物研究重点实验室,广州 510006

诃子水提物 高尿酸肾病 网络药理学 分子对接 凋亡 硫酸奎尼丁

2024

中药药理与临床
中国药理学会 四川省中医药科学院

中药药理与临床

北大核心
影响因子:0.996
ISSN:1001-859X
年,卷(期):2024.40(10)